España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Certara
CERT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.17
-0.38
-2.80%
At close: -
$13.44
0.27
2.05%
After Hours: 5:02 PM EDT
Get Report
Comment
Q4 2024 Earnings in 4 days from now on Wed Feb 26th, after the market close
Conference call scheduled in 4 days at 17:00 PM
Click to view the webcast
Certara (CERT) Forecast
News
Earnings
Certara (CERT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Certara (NASDAQ:CERT) Stock
Certara Stock (NASDAQ: CERT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 14, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, January 15, 2025
Certara shares are trading higher after the c...
Benzinga Newsdesk
Certara Sees Q4 Revenues Of $99.7M, compared ...
Benzinga Newsdesk
Certara Sees FY24 Revenue Of $384.4M Vs. Esti...
Benzinga Newsdesk
Thursday, November 07, 2024
Forecasting The Future: 4 Analyst Projections For Certara
Benzinga Insights
Barclays Maintains Equal-Weight on Certara, L...
Benzinga Newsdesk
Wednesday, November 06, 2024
Certara Sees FY24 EPS $0.41-$0.44 Vs $0.41 Es...
Benzinga Newsdesk
Certara Q3 Adj $0.13 Beats $0.11 Estimate, Sa...
Benzinga Newsdesk
Tuesday, November 05, 2024
Baird Maintains Neutral on Certara, Lowers Pr...
Benzinga Newsdesk
Tuesday, October 15, 2024
Beyond The Numbers: 4 Analysts Discuss Certara Stock
Benzinga Insights
Friday, September 27, 2024
Beyond The Numbers: 4 Analysts Discuss Certara Stock
Benzinga Insights
Certera shares are trading higher after UBS u...
Benzinga Newsdesk
UBS Upgrades Certara to Buy, Maintains Price ...
Benzinga Newsdesk
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, September 18, 2024
Certara & Ichnos Glenmark Innovation Collabor...
Benzinga Newsdesk
Wednesday, August 07, 2024
UBS Maintains Neutral on Certara, Lowers Pric...
Benzinga Newsdesk
Baird Maintains Neutral on Certara, Lowers Pr...
Benzinga Newsdesk
Certara shares are trading lower after the co...
Benzinga Newsdesk
Tuesday, August 06, 2024
Certara Q2 2024 Adj EPS $0.07 Misses $0.10 Es...
Benzinga Newsdesk
Thursday, July 11, 2024
Keybanc Maintains Overweight on Certara, Lowe...
Benzinga Newsdesk
Wednesday, July 10, 2024
JMP Securities Reiterates Market Perform on C...
Benzinga Newsdesk
Tuesday, July 09, 2024
Certara Reiterates Full Year 2024 Guidance, E...
Benzinga Newsdesk
Certara Agrees To Acquire Cheminformatics Sof...
Benzinga Newsdesk
Friday, June 28, 2024
Barclays Maintains Equal-Weight on Certara, L...
Benzinga Newsdesk
Monday, June 17, 2024
Certara Launches CoAuthor Regulatory Writing ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Certara shares are trading lower after the co...
Benzinga Newsdesk
Tuesday, May 07, 2024
Certara Sees FY24 Adj. EPS $0.41-$0.46 vs $0....
Benzinga Newsdesk
Certara Q1 2024 GAAP EPS $0.10, Inline, Sales...
Benzinga Newsdesk
Wednesday, April 10, 2024
Certara shares are trading higher after KeyBa...
Benzinga Newsdesk
Keybanc Upgrades Certara to Overweight, Annou...
Benzinga Newsdesk
Thursday, April 04, 2024
Decoding 4 Analyst Evaluations For Certara
Benzinga Insights
JMP Securities Initiates Coverage On Certara ...
Benzinga Newsdesk
Friday, March 01, 2024
Certara shares are trading higher after the c...
Benzinga Newsdesk
UBS Maintains Neutral on Certara, Raises Pric...
Benzinga Newsdesk
Analyst Scoreboard: 4 Ratings For Certara
Benzinga Insights
Jefferies Maintains Hold on Certara, Raises P...
Benzinga Newsdesk
Thursday, February 29, 2024
Certara Sees 2024 Adj. EPS $0.41-$0.46 vs $0....
Benzinga Newsdesk
Certara Q4 2023 Adj EPS $0.090 Misses $0.110 ...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Monday, February 26, 2024
Leerink Partners Initiates Coverage On Certar...
Benzinga Newsdesk
Tuesday, January 30, 2024
Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies
Natan Ponieman
Thursday, January 25, 2024
Barclays Maintains Equal-Weight on Certara, R...
Benzinga Newsdesk
Wednesday, December 13, 2023
Certara Acquires Applied BioMath; No Terms Di...
Benzinga Newsdesk
Thursday, December 07, 2023
UBS Initiates Coverage On Certara with Neutra...
Benzinga Newsdesk
Tuesday, December 05, 2023
Keybanc Initiates Coverage On Certara with Se...
Benzinga Newsdesk
Tuesday, November 21, 2023
Certara Introduces Simcyp Biopharmaceutics So...
Benzinga Newsdesk
Wednesday, November 08, 2023
Certara Reiterates FY23 Adj. EPS $0.44-$0.48 ...
Benzinga Newsdesk
Certara Q3 2023 Adj. EPS $0.11 Inline With Es...
Benzinga Newsdesk
Recap: Certara Q3 Earnings
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
